ALMKT:EPA
Mauna Kea Technologies SA
0,092 €
0,00%
(0,00) 1K
13-noy, 17:35:01 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALMKT tikeri uchun statistika yaratilmoqda...
Ochish
0,09 €
Yuqori
0,10 €
Past
0,09 €
Bozor kapitali
18,14 mln
Oʻrtacha hajm
541,14 ming
Hajmi
75,16 ming
P/E koeffitsiyenti
0,79
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26 mln
Xodimlar soni
56
Ochish
0,09 €
Yuqori
0,10 €
Past
0,09 €
Bozor kapitali
18,14 mln
Oʻrtacha hajm
541,14 ming
Hajmi
75,16 ming
P/E koeffitsiyenti
0,79
52 haftalik eng yuqori
0,23 €
52 haftalik eng past
0,07 €
Aksiya boʻyicha daromad
0,12 €
Muomaladagi aksiyalar
195,26 mln
Xodimlar soni
56
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TradingKey
·
4 soat oldin
S&P 500 Forecast: Index Poised to Retest Record High in November After 500-Point Pullback, Biggest Daily Gain in Nearly Seven Months
Foreign Policy Journal
·
4 soat oldin
Dow Jones Industrial Average (DJIA) Stays Green While Nasdaq Tumbles Nearly 1% In Sharp Rotation Trade
TradingView
·
11 soat oldin
EXCLUSIVE: S&P 500’s Sell-Off Tested Buffered ETFs: Expert Explains Why a 10% Buffer May Not Protect You as Expected
Traders Union
·
11 soat oldin
Michael Kantro: Institutional investors focus on stock picking as S&P 500 targets have lost relevance
Profil
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Mauna Kea Technologies SA haqida
CEOSacha Loiseau
Xodimlar soni56
Asos solingan2000
Bosh ofislar-
SektorHealth Care
Soha-
Veb-saytmaunakeatech.com